Search by Drug Name or NDC
NDC 70436-0203-80 Dobutamine 250 mg/20mL Details
Dobutamine 250 mg/20mL
Dobutamine is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Slate Run Pharmaceuticals. The primary component is DOBUTAMINE HYDROCHLORIDE.
Product Information
NDC | 70436-0203 |
---|---|
Product ID | 70436-203_f5cd978c-4e1d-2447-e053-2a95a90add3f |
Associated GPIs | |
GCN Sequence Number | 064535 |
GCN Sequence Number Description | dobutamine HCl VIAL 250MG/20ML INTRAVEN |
HIC3 | A1C |
HIC3 Description | INOTROPIC DRUGS |
GCN | 14575 |
HICL Sequence Number | 000040 |
HICL Sequence Number Description | DOBUTAMINE HCL |
Brand/Generic | Generic |
Proprietary Name | Dobutamine |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | dobutamine |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 250 |
Active Ingredient Units | mg/20mL |
Substance Name | DOBUTAMINE HYDROCHLORIDE |
Labeler Name | Slate Run Pharmaceuticals |
Pharmaceutical Class | Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA216131 |
Listing Certified Through | 2024-12-31 |
Package
NDC 70436-0203-80 (70436020380)
NDC Package Code | 70436-203-80 |
---|---|
Billing NDC | 70436020380 |
Package | 1 VIAL, SINGLE-DOSE in 1 CARTON (70436-203-80) / 20 mL in 1 VIAL, SINGLE-DOSE |
Marketing Start Date | 2023-04-03 |
NDC Exclude Flag | N |
Pricing Information | N/A |